Seeding of malignant renal tumor through a nephrostomy tract.
We present 2 patients who suffered from obstructive uropathy and received percutaneous nephrostomy diversion. After a series of studies, the diagnoses were transitional cell carcinoma and squamous cell carcinoma, respectively. Unfortunately, tumor seeding through a percutaneous nephrostomy tract developed after radical operation. Wide excision of recurrent tumors was performed and no local recurrence could be found after a follow-up more than 1 year later. Malignancy seeding through the percutaneous nephrostomy tract should always be kept in mind when we deal with patients of obstructive uropathy caused by suspected malignancy.
Wang
Shian-Shiang
SS
Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, ROC.
Ho
Hao-Chung
HC
Su
Chung-Kwang
CK
Chen
Wen-Ming
WM
Cheng
Chen-Li
CL
Yang
Chi-Rei
CR
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000150:complications / Q000188:drug therapy; D015251:Epirubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology / Q000601:surgery; D007680:Kidney Neoplasms / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009366:Neoplasm Seeding; D018307:Neoplasms, Squamous Cell / Q000150:complications / Q000188:drug therapy; D009403:Nephrostomy, Percutaneous / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin; D008727:Methotrexate